Search bioRxivSearch

Biology subjects

Pardo, J. V.

Publications and source records attributed to Pardo, J. V..

2 recordsLinked to original sources

Aging-related hypometabolism in the anterior cingulate cortex mediates the relationship between age vs. executive function but not vs. memory in cognitively intact elders

Elucidating the pathophysiology of cognitive decline during aging in those without overt neurodegeneration is a prerequisite to improved diagnosis, prevention, and treatment of cognitive aging. We showed previously the anterior cingulate cortex (ACC) and adjacent medial prefrontal cortex (mPFC) are centers for aging-related metabolic dysfunction that correlate with age-associated cognitive decline in healthy volunteers. Here, we examine using the extensive and well-characterized ADNI dataset the hypothesis that ACC metabolism in healthy seniors functions as a mediator in the relationship between age and executive function. In agreement with our previous findings, highly significant correlations arose between age and metabolism; metabolism and fluency; and age and fluency. These observations motivated a mediation model in which ACC metabolism mediates the relationship between age and fluency score. Significance of the indirect effect was examined by Sobel testing and bootstrapping. In these cognitively intact seniors with \"typical aging,\" there was neither a correlation between age and memory scores nor between ACC metabolism and memory scores. The metabolism in a control region, the primary motor cortex, showed no correlation with age or ACC metabolism. These findings motivate further research into aging-related ACC dysfunction to prevent, diagnose, and treat the decline in executive function associated with aging in the absence of known neurodegenerative diseases.\n\nSIGNIFICANCE STATEMENTThe pathophysiology of aging-related cognitive decline remains unclear but the anterior cingulate cortex (ACC), a major component of the anterior human attention system, shows decreasing metabolism that correlates with declining executive function despite otherwise intact cognition. Here, the relationships between ACC metabolism, age, executive function, and memory were examined using the large, public, ADNI database. Earlier findings were confirmed. In addition, ACC metabolism was found a mediator between age and executive function. In contrast, no correlation arose between memory and age or between memory and ACC metabolism. No correlations surfaced when using the metabolism of the right primary motor cortex as a control region. Development of preventive medicine and novel treatments will require elucidation of aging-related ACC pathophysiology requiring further research.

neuroscience

A preliminary study of brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination

Treatment-resistant depression (TRD) occurs in many patients and causes high morbidity and mortality. Because TRD subjects are particularly difficult to study especially longitudinally, biological data remain very limited. In a preliminary study to judge feasibility and power, 25 TRD patients were referred from specialty psychiatric practices. All were severely and chronically depressed and mostly had comorbid psychiatric disorders as is typical in TRD. Nine patients were able to complete all required components of the protocol that included diagnostic interview; rating scales; clinical magnetic resonance imaging; medication washout; treatment with maximally tolerated olanzapine-fluoxetine combination for 8 weeks; and pre- and post-treatment fluorodeoxyglucose positron emission tomography. This drug combination is an accepted standard of treatment for TRD. Dropouts arose from worsening depression, insomnia, and anxiety. One patient remitted; three responded. A priori regions of interest included the amygdala and subgenual cingulate cortex (sgACC; BA25). Responders showed decreased metabolism with treatment in the right amygdala that correlated with clinical response; no significant changes in BA25; better response to treatment the higher the baseline BA25 metabolism; and decreased right ventromedial prefrontal metabolism (VMPFC; broader than BA25) with treatment which did not correlate with depression scores. The baseline metabolism of all individuals showed heterogeneous patterns when compared to a normative metabolic database. Although preliminary given the sample size, this study highlights several issues important for future work: marked dropout rate in this study design; need for large sample size for adequate power; baseline metabolic heterogeneity of TRD requiring careful subject characterization for future studies of interventions; relationship of amygdala activity decreases with response; and the relationship between baseline sgACC and VMPFC activity with response. Successful treatment of TRD with olanzapine-fluoxetine combination shows changes in cerebral metabolism similar to those seen in treatment-responsive major depression.

neuroscience